Recent

% | $
Quotes you view appear here for quick access.

Penn National Gaming Inc. Message Board

jcbrowns 119 posts  |  Last Activity: 11 hours ago Member since: Jan 10, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Resp[onse from Pomerantz LLP:

    by jcbrowns Jul 22, 2015 10:54 AM
    jcbrowns jcbrowns 11 hours ago Flag

    I keep waiting for a response on that matter as well as some information on the cancer story with rats. I also don't understand why the FDA did not approve the Fast Track and Breakthrough designations. This stock could be the best thing since apple pie and ice cream or the worst dog one ever had in a portfolio, and at this point I don't want to turn a good profit into a big loss. In the interim, I have increased my position in HZNP as a better alternative, but I will keep my eyes on RDUS.

  • jcbrowns jcbrowns 14 hours ago Flag

    Don't trust Zack's - they have changed there opinion twice in one week in the past. In my opinion, there recommendation of a stock is meaningless.

    If abaloparatide is approved by the FDA, this stock will hit $150 in little time; however, it may not be approved. Lately, I have begun to question whether approval will be granted because of the big sell off from the $80 area around July 17. Some weakness in the stock has been observed since than. I am also a little disappointed that the company has not responded to my question as to whether abaloparatide might cause cancer in rats as is reported in the case of Teriparatide. I have been out of the stock since last week, but I could return if conditions look right.
    Good luck to the longs.

  • jcbrowns by jcbrowns Jul 28, 2015 12:46 AM Flag

    Over one year ago Ned Davis Research predicted gold would fall to a low near $700 per ounce. I thought they were nuts; however, the estimate is beginning to look like a real possibility. Gold may be the best value in the world, but with the powers of the big manipulators, the rising dollar, and continuing talk of rising interest rates, I would not go near gold or the miners with a ten foot pole. Good luck to the longs in any case.

  • Reply to

    Lone Pine Capital

    by alerts_now Jul 27, 2015 5:14 PM
    jcbrowns jcbrowns Jul 27, 2015 7:05 PM Flag

    That should help the stock price a little.

    Sentiment: Strong Buy

  • Reply to

    I hope Tim pulls the bid

    by junglejim888 Jul 27, 2015 10:10 AM
    jcbrowns jcbrowns Jul 27, 2015 2:00 PM Flag

    I am with you on pulling the bid. The original bid was a reasonable offer - beyond that I think it is a bad idea - especially so in this overpriced market.

  • Reply to

    A cautionay tale

    by ayla5668 Jul 24, 2015 5:01 AM
    jcbrowns jcbrowns Jul 24, 2015 10:24 AM Flag

    Any stock you buy is a risk. If you want to be 100% safe, one does not buy stock. The problem is that without taking risk by buying stock - you take a bigger risk by all the other alternatives. I think HZNP and TW represent a good balance of reward versus risk. If you believe otherwise, my advice is to sell your HZNP shares and relax and enjoy life. Good luck.

    Sentiment: Strong Buy

  • Reply to

    $33 Ceiling?

    by geringerart Jul 23, 2015 10:56 PM
    jcbrowns jcbrowns Jul 24, 2015 12:29 AM Flag

    Geringerart - Your logic is exactly correct. Unless there is greater potential than we are aware of, I trust that TW will not go higher on the bid. Good luck.

  • Reply to

    SEC Form 8K:

    by jcbrowns Jul 22, 2015 11:04 PM
    jcbrowns jcbrowns Jul 23, 2015 12:30 AM Flag

    Thanks for that information.

  • jcbrowns by jcbrowns Jul 22, 2015 11:04 PM Flag

    I have some trepidation about the following statement in the SEC Form 8k filed by RDUS:

    "The NDA that we plan to submit to the FDA for abaloparatide-SC as a proposed treatment for osteoporosis, will need to include the 24-month fracture data from the first six months of the alendronate extension study of the abaloparatide and placebo groups from our Phase 3 clinical trial. We also must complete several additional studies, including, but not limited to, a thorough QT Phase 1 study and a Phase 1 pharmacokinetic study in renal patients. The results of these studies will have an important bearing on the approval of abaloparatide."

    I was not aware of the need for a thorough QT Phase 1 study and a Phase 1 pharmacokinetic study in renal patients. What is the typical length of these studies? All responses deeply appreciated.

  • Reply to

    $74 Secondary Price

    by b1g_brothr Jul 22, 2015 8:17 PM
    jcbrowns jcbrowns Jul 22, 2015 10:39 PM Flag

    If the shares are to be sold at $84, it appears to me that JPM, et.al. are necessarily going to have to support the share price somewhere above $84 during the disposing of the 4 million shares - or they will not be bought by the public. After the disposition of the shares, it is anyone's guess what will happen. Again, I wish good luck to all that are long.

  • Reply to

    Denial of breakthrough designation

    by stevencall66 Jul 22, 2015 7:10 PM
    jcbrowns jcbrowns Jul 22, 2015 7:24 PM Flag

    I wish I knew the reason for denial and how more lenient regulations to be approved by the US Congress might affect future actions by the FDA - but , of course, I don't know. I made a nice profit in this stock - but I think I had enough. I have no idea what will happen to this stock, and for now I will stand back and observe. Good luck to all longs.

  • Reply to

    same deal. same answer.

    by jh050562 Jul 21, 2015 8:25 PM
    jcbrowns jcbrowns Jul 22, 2015 2:40 PM Flag

    I am a HZNP shareholder - and I definitely don't want TW to pursue your company. In my opinion, your stock is very over-priced. I would not short DEPO, but I definitely would not buy or hold the stock. I predict that the stock price will erode over the next two weeks. Good luck if you are long as I never wish that anyone have bad luck.

    Sentiment: Sell

  • Reply to

    Resp[onse from Pomerantz LLP:

    by jcbrowns Jul 22, 2015 10:54 AM
    jcbrowns jcbrowns Jul 22, 2015 12:04 PM Flag

    I agree. Management should respond immediately. Stock is down big and and absolutely no information.
    I would like to hear from the party or parties that contacted Pomerantz. What do they think happened here and why so quick to file a lawsuit?

  • There apparently may be evidence that RDUS management knew of the the denial of breakthrough therapy designation for Abaloparatide before July 21 when it released information to the public. I am beginning to wonder if that is what caused the big sell-off from the high around 83 (premarket) on Monday. I don't like the whole situation. and I don't have any idea what will happen to this stock near term. Good luck to all longs.

  • Reply to

    Be Reminded of This Bill Going thru Congress!

    by jcbrowns Jul 22, 2015 8:12 AM
    jcbrowns jcbrowns Jul 22, 2015 9:07 AM Flag

    I don't understand it. I placed a call to Pomerantz LLP this morning - no response as yet. I will post any response I receive.

    Sentiment: Strong Buy

  • The House of Representatives just passed the Twenty-First Century Cures Act that broadens the Fast Track Program, including the Accelerated Approval Pathway and the Breakthrough Therapy designation. This should speed-up the approval process for many drugs that are now in various stages of clinical testing - including our Abaloparatide and RAD-1901. The Bill was unanimously approved in Committee and passed in the House by a margin of 377-44. There is no serious opposition to this Bill in the Senate. Whatever RDUS was worth prior to the passing of this Bill, it is worth more now.

    With the appeal RDUS is making to the FDA, we stand a good chance of getting the Breakthrough Therapy designation for Abaloparatide. Don't make the mistake of selling at this time of extreme market pressure.

    Sentiment: Strong Buy

  • Reply to

    My two cents

    by junglejim888 Jul 20, 2015 8:02 AM
    jcbrowns jcbrowns Jul 21, 2015 11:44 PM Flag

    I am a HZNP shareholder and I strongly don't want any part of your company; therefore, it is my most sincere wish that your management not accept any horizon deal. The $29+ is as high as HZNP should go. I hope you get your wish - and good luck.

    Sentiment: Strong Sell

  • jcbrowns jcbrowns Jul 21, 2015 11:27 PM Flag

    It may be the top for the very near term, but I am betting a much higher top is in store for mid-October.
    Time will tell.

    Sentiment: Strong Buy

  • The issuance of a small additional number of shares provides the additional money needed for growth. This is good news - not bad news. If your selling shares, you are making a BIG MISTAKE. I will buy more shares if the stock moves lower - thanks to the sellers.

    Sentiment: Strong Buy

  • jcbrowns by jcbrowns Jul 21, 2015 4:16 PM Flag

    It is only approximately 3.5 Million shares. The sell off is ridiculous.

    Sentiment: Strong Buy

PENN
18.68+0.02(+0.11%)Jul 28 4:00 PMEDT